Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Key Points: Hematopoietic cell–targeted antibody-drug conjugate preconditioning is highly effective for platelet gene therapy in hemophilia A mice. Platelet-specific FVIII gene therapy can effectively prevent a needle-induced knee joint injury in hemophilia A mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Myeloablative conditioning is required for all cell-based therapeutics but has been associated with myelodysplasia”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huang, E., Nocka, K., Beier, D. R., Chu, T.-Y., Buck, J., Lahm, H.-W., Wellner, D., Leder, P., & Besmer, P. (1990) · Cell · doi:10.1016/0092-8674(90)90303-v · Cited by 1,155
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
Bi, L., Lawler, A. M., Antonarakis, S. E., High, K. A., Gearhart, J. D., & Kazazian, H. H. (1995) · Nature Genetics · doi:10.1038/ng0595-119 · Cited by 593
Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell Niches
Czechowicz, A., Kraft, D., Weissman, I. L., & Bhattacharya, D. (2007) · Science · doi:10.1126/science.1149726 · Cited by 432
Self-citationBlijlevens, N., Donnelly, J., & De Pauw, B. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702447 · Cited by 266 · cited 1×
“Prior preconditioning regimens used in our platelet gene therapy protocols involve total body irradiation (TBI) and/or chemotherapy using cytotoxic drugs, which are nontargeted and genotoxic, carrying potential risks for tissue damage, cytopenias, and secondary malignancy.(5-8) The potential toxicities associated with…”
Palchaudhuri, R., Saez, B., Hoggatt, J., Schajnovitz, A., Sykes, D. B., Tate, T. A., Czechowicz, A., Kfoury, Y., Ruchika, F., Rossi, D. J., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3584 · Cited by 217 · cited 2×
“ADC preconditioning, HSC transduction, and HSCT ADCs were prepared by combining biotinylated antibody with streptavidin-SAP, as previously described.(16-18) The combination of CD45.”
BackgroundMethodSelf-citationCzechowicz, A., Palchaudhuri, R., Scheck, A., Hu, Y., Hoggatt, J., Saez, B., Pang, W. W., Mansour, M. K., Tate, T. A., Chan, Y. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08201-x · Cited by 197 · cited 2×
“ADC preconditioning, HSC transduction, and HSCT ADCs were prepared by combining biotinylated antibody with streptavidin-SAP, as previously described.(16-18) The combination of CD45.”
BackgroundMethodSelf-citationShi, Q. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28416 · Cited by 191 · cited 2×
“FVIII expression levels in platelets and plasmas were quantitated using a chromogenic assay, as previously described.(1,29-31)”
MethodSelf-citationHematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
Chhabra, A., Ring, A. M., Weiskopf, K., Schnorr, P. J., Gordon, S., Le, A. C., Kwon, H.-S., Ring, N. G., Volkmer, J., Ho, P. Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0501 · Cited by 172 · cited 1×
“However, utilizing anti-CD117 antibody alone as a preconditioning for BMT/HSCT was insufficient in wild-type (WT) immunocompetent mice, yet a combination of anti-CD117 antibody with low-dose TBI or a CD47 antibody was effective.(12,13) Subsequently, CD45 (leukocyte common antigen) or CD117 antibodydrug conjugated to p…”
BackgroundFactor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment
Yarovoi, H. V., Kufrin, D., Eslin, D. E., Thornton, M. A., Haberichter, S. L., Shi, Q., Zhu, H., Camire, R., Fakharzadeh, S. S., Kowalska, M. A., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1519 · Cited by 156
Self-citationEffects of the stem cell factor, c-kit ligand, on human megakaryocytic cells
Avraham, H. K., Vannier, E. G., Cowley, S. A., Jiang, S., Chi, S., Dinarello, C. A., Zsebo, K. M., & Groopman, J. (1992) · Blood · doi:10.1182/blood.v79.2.365.365 · Cited by 139 · cited 1×
“Indeed, it has been shown that CD117 is expressed on HSCs, as well as on megakaryocytes.(39-42) In addition, a recent study demonstrated that different stages of megakaryocytes could have various levels of CD45 expression, with abundant expression on early progenitors and adult megakaryocytes.”
Background
Cited by
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Autosomal recessive osteopetrosis: mechanisms and treatments
Penna, S., VILLA, A. M., & Capo, V. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048940 · Cited by 63
“The CD117 ADC was also exploited successfully in MHC-mismatched allotransplantation (Li et al., 2019b) and in hemophilia A GT mice (Gao et al., 2019).”
Therapy Development by Genome Editing of Hematopoietic Stem Cells
Koniali, L., Lederer, C. W., & Kleanthous, M. (2021) · Cells · doi:10.3390/cells10061492 · Cited by 54
Saha, A., Hyzy, S. L., Lamothe, T. L., Hammond, K. J., Clark, N., Lanieri, L., Bhattarai, P. R., Palchaudhuri, R., Gillard, G. O., Proctor, J., et al. (2022) · Blood · doi:10.1182/blood.2021012366 · Cited by 49
Stem cell–derived CAR T cells traffic to HIV reservoirs in macaques
Barber-Axthelm, I. M., Barber-Axthelm, V. R. B., Sze, K. Y., Zhen, A., Suryawanshi, G. W., Chen, I. S. Y., Zack, J. A., Kitchen, S. G., Kiem, H., & Peterson, C. W. (2021) · JCI Insight · doi:10.1172/jci.insight.141502 · Cited by 43
Metadata
- Authors
- Gao, C., Schroeder, J. A., Xue, F., Jing, W., Cai, Y., Scheck, A., Subramaniam, S., Rao, S., Weiler, H., Czechowicz, A., & Shi, Q.
- Affiliations
- Harbin Medical University (CN)
- Children's Hospital of Wisconsin (US)
- Versiti Blood Center of Wisconsin (US)
- Boston Children's Hospital (US)
- Blood Research Institute, Versiti Wisconsin, Milwaukee, WI;
- ORCID
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2019-09-12
- Volume
- 3
- Issue
- 18
- Pages
- 2700-2711
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- PMC
- PMC6759737
- OpenAlex
- W2972398700
- Cited by
- 51
- References
- 45
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 13 · 2020: 9
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Blood Advances (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- University of Pennsylvania
- Midwest Athletes Against Childhood Cancer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-102035, R01HL102035)
- National Cancer Institute (R01CA204231)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- hemophilia A, factor VIII, hematopoietic stem cell gene therapy, saporin, CD117, CD8, immune tolerance, lentiviral vectors, engraftment, hemostasis, hemarthrosis
- MeSH terms
- Animals, Blood Platelets, Hemophilia A, Humans, Male, Genetic Therapy, Immunoconjugates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. https://app.cochat.ai/papers/10.1182/bloodadvances.2019000516
- The paper
- Gao, C., Schroeder, J. A., Xue, F., Jing, W., Cai, Y., Scheck, A., Subramaniam, S., Rao, S., Weiler, H., Czechowicz, A., & Shi, Q. (2019). Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Advances. https://doi.org/10.1182/bloodadvances.2019000516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.